| answer text |
<p>The UK government has secured early access to 332 million vaccines doses through
supply agreements with five separate vaccine developers. This includes agreements
with:</p><ul><li>Pfizer/BioNTech for 135 million doses</li><li>University of Oxford/AstraZeneca
for 100 million doses</li><li>Moderna for 17 million doses</li><li>Novavax for 60
million doses</li><li>Janssen for 20 million doses</li></ul><p>Of these, Pfizer/BioNTech,
University of Oxford/AstraZeneca and Moderna vaccines have received MHRA regulatory
approval and are currently in deployment in the UK. The Janssen vaccine has also received
regulatory approval and deliveries are expected later this year. The Novavax vaccine
is yet to receive regulatory approval, so timings for delivery are dependent on this.</p><p>Due
to commercial sensitivities, we are not able to provide detailed timelines for delivery.</p><p>We
are in regular contact with the vaccine manufacturers and are confident in our vaccine
supplies going into the autumn/ winter, having already secured the doses we need for
everyone in the UK who requires a booster.</p>
|
|
